Children with sickle cell disease: are they protected from serious COVID-19?
Despite SCD being a chronic disease with known specific complications, there has been a claim that COVID-19 infection adds further risk. The results of this study suggest that the overall outcome of COVID-19 was favorable, with no reported mortality. Further research is needed to understand the factors that contributed to this favorable outcome. In children with SCD, it is still questionable whether hydroxyurea is one of the protective factors against severe COVID-19. Validation through large-scale research is recommended.
Authors
- Rana Hassan Almaghrabi
- Fahad Alabbas (ORCID: https://orcid.org/0000-0001-6910-1369)
- Hayam Aldeeb
- Abdalla Mohamed Zayed
- Huda Elfaraidi
- Azzah Alzahrani
- Aljawhara Almanea
- Walaa Shahin
- Ghaleb Elyamany (ORCID: https://orcid.org/0000-0002-6334-4500)
- Fatma Albatniji
- Abdullah Tammas
- Tahani Ali (ORCID: https://orcid.org/0000-0001-8103-8518)
- Majed Alsulami
Institutions
- Riyadh Armed Forces Hospital (SA)
- Cairo University (EG)
- King Fahd Medical City (SA)
- King Fahd Armed Forces Hospital (SA)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2024-10-07
- DOI
- https://doi.org/10.3389/fped.2024.1337377
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00